Abstract：Objective: To investigate the relationship between lipid metabolism, serum levels of insulin-like growth factor-1 (IGF-1) and glycosylated hemoglobin (HbA1c) and the nature of thyroid nodules in patients with type 2 diabetes mellitus (T2DM). Methods: 137 patients with T2DM combined with thyroid nodules treated in our hospital from May 2020 to May 2022 were selected as the observation group, while 140 patients with T2DM alone were selected as the control group, the differences in lipid metabolism, IGF-1, HbA1c, etc. between the two groups were compared, and the differences in lipid metabolism, IGF-1, HbA1c, etc. between patients with benign and malignant nodules in the observation group were analyzed. Results: The course of T2DM, fasting blood glucose (FBG), fasting insulin (FINS), glycosylated hemoglobin (HbA1c), insulin resistance index (HOMA-IR), triglyceride (TG), TG/HDL-C and IGF-1 in the observation group were (10.50 ± 2.43) years, (11.40 ± 2.11) mmol/L, (24.49 ± 3.32) mIU/L, (9.60 ± 1.83)%, (12.45 ± 2.11), (4.14 ± 1.02) mmol/L, (3.05 ± 0.92) and (220.10 ± 70.20) ng/ml, respectively, which was significantly higher than that in the control group (P<0.05). There was no significant difference between the observation group and the control group in blood glucose at 2h after meal (2hPG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), TC/HDL-C and LDL-C/HDL-C (P>0.05). HbA1c, TG, TG/HDL-C and IGF-1 in patients with malignant nodules of observation group were (10.21 ± 1.60)%, (4.76 ± 1.56) mmol/L, (3.50 ± 0.90) and (243.32 ± 51.26) ng/ml, respectively, higher than those in patients with benign nodules (P<0.05). TG, TG/HDL-C were positively correlated with HbA1c (P<0.05). IGF-1 had no significant correlation with TG, TG/HDL-C and HbA1c (P>0.05). The area under ROC curve predicted by TG, TG/HDL-C, IGF-1, HbA1c to predict malignant nodules were 0.621, 0.705, 0.727, 0.687 respectively (P<0.05). Conclusion: In T2DM patients with thyroid nodules, lipid metabolism is significantly abnormal, IGF-1 and HbAIc are significantly increased, and TG, TG/HDL-C, IGF-1 and HbA1c has certain application value in predicting benign and malignant thyroid nodules.
何旭梅, 宋惠杰, 魏若萱, 陈蔚, 刘佳维. 脂代谢 IGF-1及HbA1c水平与T2DM合并甲状腺结节性质的关系研究[J]. 河北医学, 2023, 29(6): 977-982.
HE Xumei, SONG Huijie, et al. The Relationship between Lipid Metabolism IGF-1 and HbA1c Levels and the Nature of T2DM Combined with Thyroid Nodules. HeBei Med, 2023, 29(6): 977-982.
[1] Kamp Y J M O D,Ligt M D,Dautzenberg B,et al.Erratum.Effects of the SGLT2 inhibitor dapagliflozin on energy metabolism in patients with type 2 diabetes:a randomized,double-blind crossover trial[J].Diabetes Care,2021,44(8):1334-1343. [2] Cao C,Cui ZL,Miao J,et al.The correlation between microalbuminuria and thyroid nodules in type 2 diabetic mellitus[J].Int Endocrinol,2022,2022(8):e2789\. [3] Condorelli RA,Cannarella R,Aversa A,et al.Effects of slow-acting metformin treatment on the hormonal and morphological thyroid profile in patients with insulin resistance[J].Pharmaceutics,2022,14(10):1987-1988. [4] Sreekumar A,Jayalekshmi PA,Nandakumar A,et al.Thyroid nodule prevalence among women in areas of high natural background radiation,Karunagappally,Kerala,India[J].Endocrine,2020,67(1):124-130. [5] Erturk MS,Cekic B,Celik M,et al.Microwave ablation of symptomatic benign thyroid nodules:short- and long-term effects on thyroid function tests,thyroglobulin and thyroid autoantibodies[J].Clin Endocrinol (Oxf),2021,94(4):677-683. [6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):53-54. [7] 李蕊娟,李景丽,刘双双.2型糖尿病患者甲状腺体积与代谢相关指标关系研究[J].华南预防医学,2021,47(5):664-666. [8] 常星宇,傅松波,汤旭磊,等.脂代谢异常人群甲状腺结节检出情况及相关因素分析[J].中华地方病学杂志,2021,40(9):718-723. [9] 李磊,彭红叶,阎早芳,等.近十年我国2型糖尿病人群甲状腺结节患病率Meta分析[J].中日友好医院学报,2021,35(3):169-171,192 [10] 陈璟泰,侯令密,唐云辉,等.S-Detect对甲状腺结节良恶性鉴别诊断价值的Meta分析[J].中国全科医学,2021,24(30):3814-3820. [11] 陆峰,周添燕,韩星星,等.2型糖尿病患者血清胰岛素样生长因子1、促甲状腺激素及胰岛素抵抗程度与甲状腺结节影像报告和数据系统分级的相关性[J].中国医师进修杂志,2022,45(9):794-799. [12] 李小勤,崔凡,钱增堃,等.2型糖尿病患者体内胰岛素样生长因子1与甲状腺结节的相关性研究[J].医学研究杂志,2021,50(2):53-56.
2023, Vol. 29 
冀公网安备13080202000677号